1.
PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial.
Jampol Lee M, Odia Isoken, Glassman Adam R, Baker Carl W, Bhorade Anjali M, Han Dennis P et al.
RetinaJan 20190 citationsRandomized Controlled Trial
Comparing ranibizumab vs. PRP for proliferative diabetic retinopathy, ranibizumab caused more RNFL thinning, likely from reduced edema, not nerve loss, which is clinically reassuring for glaucoma monitoring.